Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88763576 | 8876357 | 6 | F | 20160920 | 20121031 | 20160923 | EXP | PHMT2006CA02225 | NOVARTIS | 0.00 | M | Y | 0.00000 | 20160923 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 88763576 | 8876357 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO | 21008 | 30 | MG | /month | |||||||
| 88763576 | 8876357 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO, EVERY 4 WEEKS | 21008 | 20 | MG | /month | |||||||
| 88763576 | 8876357 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, QMO, EVERY 4 WEEKS | 21008 | 30 | MG | /month | |||||||
| 88763576 | 8876357 | 4 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 60 MG, QMO, EVERY 4 WEEKS | 21008 | 60 | MG | /month | |||||||
| 88763576 | 8876357 | 5 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | UNK UKN, UNK | U | 0 | |||||||||
| 88763576 | 8876357 | 6 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | UNK UKN, UNK | U | 0 | |||||||||
| 88763576 | 8876357 | 7 | C | LOSEC | OMEPRAZOLE | 1 | Unknown | UNK UKN, UNK | U | 0 | |||||||||
| 88763576 | 8876357 | 8 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Unknown | UNK UKN, UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 88763576 | 8876357 | 1 | Carcinoid tumour |
| 88763576 | 8876357 | 5 | Product used for unknown indication |
| 88763576 | 8876357 | 6 | Product used for unknown indication |
| 88763576 | 8876357 | 7 | Product used for unknown indication |
| 88763576 | 8876357 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 88763576 | 8876357 | OT |
| 88763576 | 8876357 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 88763576 | 8876357 | Blood glucose increased | |
| 88763576 | 8876357 | Blood potassium decreased | |
| 88763576 | 8876357 | Blood pressure decreased | |
| 88763576 | 8876357 | Blood pressure increased | |
| 88763576 | 8876357 | Diarrhoea | |
| 88763576 | 8876357 | Drug ineffective | |
| 88763576 | 8876357 | Fatigue | |
| 88763576 | 8876357 | Flushing | |
| 88763576 | 8876357 | Hepatic lesion | |
| 88763576 | 8876357 | Hepatic neoplasm | |
| 88763576 | 8876357 | Injection site mass | |
| 88763576 | 8876357 | Injection site pain | |
| 88763576 | 8876357 | Musculoskeletal stiffness | |
| 88763576 | 8876357 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 88763576 | 8876357 | 1 | 20060811 | 200806 | 0 | |
| 88763576 | 8876357 | 2 | 200806 | 20081006 | 0 | |
| 88763576 | 8876357 | 3 | 20081103 | 2015 | 0 | |
| 88763576 | 8876357 | 4 | 2015 | 0 |